Sangamo BioSciences | Ventas





Ventas Cambio Fecha
Alaunos Therapeutics USD 2K 2K 2025-03
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amgen USD 9.9B 340M 2025-12
Bayer EUR 9.66B 1.08B 2025-09
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 1.89M 631K 2025-09
CSL USD 3.54B 4.68B 2025-06
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.18B 37.55M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
J&J USD 24.6B 610M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Sangamo BioSciences Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.